New study seeks to reduce risks of second radiation for lung cancer
NCT ID NCT06950073
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study tracks 500 lung cancer patients receiving a second round of high-dose radiation to the chest. Researchers will collect data on side effects and survival to find safer ways to deliver repeat radiation. The goal is to help doctors personalize treatment and reduce severe toxicity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide the data needed to make reirradiation safer for lung cancer patients with recurrent tumors.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data but does not test a new therapy, so direct patient benefit is not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Jutland, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Can precision protons spare the bowel in prostate cancer?
- Your Tumor's DNA might predict immunotherapy success